PureCycle Technologies Azioni (NASDAQ: PCT)

Ultime notizie per PureCycle Technologies (NASDAQ:PCT) Azioni

PURECYCLE TECHNOLOGIES INC

PureCycle Technologies

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

NTIC

Un&#39;analisi svela tre società sottovalutate pronte a sovraperformare il mercato: è il momento di guardare oltre i titoli più blasonati?

3 titoli da tenere d&#39;occhio (potrebbero essere un grosso affare)

Macro Economic Events

Global

Economics

iShares MSCI Israel Capped Investable Market Index Fund

Reuters Reports Syrian Druze Religious Leader Saying They Reached Ceasefire Agreement With Syrian Government

Tempus AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) shares are trading higher Wednesday after the company announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its <a href="https://www.benzinga.com/pressreleases/25/07/b46439193/tempus-receives-u-s-fda-510-k-clearance-for-tempus-ecg-low-ef-software">ejection fraction software</a>.
What Happened: Tempus said the FDA granted it 510(k) clearance for its Tempus ECG-Low EF software, which uses AI to identify patients with a potential left ventricular ejection fraction. 
Ejection fraction measures the percentage of blood that the heart pumps out with each beat. The ECG-AI device is Tempus AI&#8217;s second FDA-cleared device.
&#8220;With Tempus ECG-Low EF, we&#8217;re adding another powerful tool to the hands of clinicians to help them identify patients at risk for serious cardiovascular conditions much earlier in their care journey,&#8221; said Brandon Fornwalt, senior vice president of Cardiology at Tempus AI.
&#8220;Detection of LVEF is essential for undiagnosed patients, and this technology enables us to deliver that capability at scale to transform patient care.&#8221;
<h3 class="wp-block-heading">How To Buy TEM Stock</h3>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Tempus AI's case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
TEM Price Action: <a href="http://benzinga.com/quote/tem">Tempus AI shares </a>were up 4.8% at $58.58 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46435552/larry-ellison-surges-past-mark-zuckerberg-to-become-worlds-second-richest-person-as-oracles-ai-deals-with-openai-us-government-drive-massive-stock-surge">Larry Ellison Surges Past Mark Zuckerberg To Become World&#8217;s Second-Richest Person As Oracle&#8217;s AI Deals With OpenAI, US Government Drive Massive Stock Surge</a></li>
</ul>
Photo: Piotr Swat/Shutterstock.com

Movers

Tempus AI Stock Is Rising Wednesday: What's Happening?

Stifel analyst Jeffrey Stantial maintains Flutter Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>) with a Buy and raises the price target from $315 to $353.

Price Target

Analyst Ratings

FLUT

Stifel Maintains Buy on Flutter Entertainment, Raises Price Target to $353

Shares of Plug Power Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) are trading lower Wednesday morning. The continued selling pressure follows a two-day slide that erased some recent gains, leaving investors to weigh long-term growth against near-term financing pressures.
What To Know: The recent downturn was triggered by a July 9 prospectus filing for the potential resale of up to <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46398722/plug-powers-hot-streak-stalls-as-wall-street-frets-over-warrant-surprise">31.5 million shares</a> by a selling stockholder. While Plug Power will not receive proceeds, the filing stoked investor concerns over share dilution, contributing to a pullback that began Monday.
This pressure countered a rally fueled by <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46423504/plug-power-stock-is-sliding-tuesday-whats-going-on">positive developments</a>. Plug recently secured an expanded, lower-cost hydrogen supply agreement through 2030, which CEO Andy Marsh highlighted as a &#8220;win for… our margin profile.&#8221; 
Sentiment was also boosted by President Donald Trump signing the &#8220;One Big Beautiful Bill,&#8221; which extended the 45V clean hydrogen tax credit by two years.
Further bolstering the bull case, CFO Paul Middleton <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46120866/whats-going-on-with-plug-power-stock-12">purchased</a> 650,000 shares in June, signaling strong executive confidence in the company&#8217;s trajectory. Currently, investors appear to be balancing these strategic wins and insider confidence against the potential dilution, resulting in Wednesday&#8217;s downward trading action.
Benzinga Edge Rankings: According to <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a> stock rankings, Plug Power presents a mixed quantitative profile. The system, which scores stocks on four key factors, gives Plug a very low Momentum score of 7.75 and a low Growth score of 15.33, suggesting weak recent price performance and lagging fundamental growth compared to its peers.
However, the stock stands out with a very high Value score of 75.09. This indicates that despite its poor momentum and growth metrics, the stock may be considered undervalued based on its current price relative to its fundamental financial data.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Plug shares are trading lower by 1.16% to $1.52 Wednesday morning. The stock has a 52-week high of $3.34 and a 52-week low of 69 cents.
<h2 class="wp-block-heading">How To Buy PLUG Stock</h2>
By now you're likely curious about how to participate in the market for Plug Power &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Plug Power, which is trading at $1.53 as of publishing time, $100 would buy you 65.36 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46442422/cisco-is-quietly-beating-the-ai-hype-should-investors-pay-closer-attention">Cisco Is Quietly Beating The AI Hype—Should Investors Pay Closer Attention?</a></li>
</ul>
Image: Shutterstock

PLUG

What's Going On With Plug Power Stock Wednesday?

Stifel analyst Jeffrey Stantial maintains DraftKings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) with a Buy and lowers the price target from $53 to $51.

DKNG

Stifel Maintains Buy on DraftKings, Lowers Price Target to $51

Citigroup analyst Vikram Bagri maintains PBF Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBF#NYSE">PBF</a>) with a Neutral and raises the price target from $16 to $29.

Citigroup Maintains Neutral on PBF Energy, Raises Price Target to $29

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLB#NYSE">CLB</a>) with a Hold and lowers the price target from $13 to $12.

Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $12

Benchmark analyst Todd Brooks reiterates Red Robin Gourmet Burgers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) with a Buy and maintains $12 price target.

Reiteration

RRGB

Benchmark Reiterates Buy on Red Robin Gourmet Burgers, Maintains $12 Price Target

Stifel analyst Stephen Gengaro maintains Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) with a Buy and lowers the price target from $50 to $49.

Stifel Maintains Buy on Baker Hughes, Lowers Price Target to $49

WIIM

NUWE

Nuwellis shares are trading higher after the company announced it secured a U.S. patent for an extracorporeal blood filtering machine and methods.

Stifel analyst Stephen Gengaro maintains Atlas Energy Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NYSE">AESI</a>) with a Buy and lowers the price target from $15 to $14.5.

AESI

Stifel Maintains Buy on Atlas Energy Solutions, Lowers Price Target to $14.5

GameSquare Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAME#NASDAQ">GAME</a>) shares are soaring Wednesday as the company prepares to host a conference call to review its Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) <a href="https://www.benzinga.com/pressreleases/25/07/n46430082/gamesquare-schedules-conference-call-to-review-100-million-ethereum-treasury-strategy">treasury strategy</a>.
What To Know: GameSquare will discuss its previously announced Ethereum strategy on a conference call scheduled for 12 p.m. ET. The company believes its strategy can deliver more than&nbsp;$10 million&nbsp;of incremental annual profitability.
GameSquare CEO Justin Kenna, Dialectic founder&nbsp;Ryan Zurrer and Goff Capital&#8217;s Rhydon Lee will provide an overview of Dialectic&#8217;s proprietary&nbsp;Ethereum yield strategy.&nbsp;Dialectic is a Swiss capital firm focused on alternative assets.
The news comes after GameSquare announced an offering last week and said it intends to use the proceeds to launch an Ethereum strategy. GameSquare priced the underwritten offering of approximately 8.42 million shares at 95 cents per share for gross proceeds of approximately $8 million.&nbsp;
&#8220;After last week&#8217;s highly successful capital raise and investment in&nbsp;ETH, we are excited to share more details on our treasury strategy and showcase the exciting opportunity ahead,&#8221; Kenna said.
&#8220;We believe our relationship with Dialectic and new treasury management program deserves to be evaluated not just as a balance sheet investment, but as a yield-generating business vertical with real cash flow. It materially strengthens our valuation profile and reinforces our positioning at the intersection of media, gaming, technology and digital assets.&#8221;
Multiple companies have announced Ethereum strategies in recent months, including&nbsp;BitMine Immersion Technologies, SharpLink Gaming, Bit Digital&nbsp;and&nbsp;BTCS Inc.
GAME Price Action: <a href="http://benzinga.com/quote/GAME">GameSquare shares</a> were up 59.3% at $2.40 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/07/46432615/bitmine-immersion-technologies-stock-surges-after-hours-whats-going-on">BitMine Immersion Technologies Stock Surges After Hours: What&#8217;s Going On?</a></li>
</ul>
Photo: alfernec/Shutterstock.com

$ETH

GAME

GameSquare Holdings Stock Is Surging Wednesday: What's Going On?

Citigroup analyst Vikram Bagri maintains Marathon Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>) with a Neutral and raises the price target from $144 to $182.

Citigroup Maintains Neutral on Marathon Petroleum, Raises Price Target to $182

Susquehanna analyst Bascome Majors maintains JB Hunt Transport Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) with a Neutral and raises the price target from $155 to $157.

JBHT

Susquehanna Maintains Neutral on JB Hunt Transport Servs, Raises Price Target to $157

GameSquare Holdings shares are trading higher after the company announced it will schedule a conference call to review a $100 million Ethereum treasury strategy.

Shares of Nuwellis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) are skyrocketing Wednesday morning after the medical technology company announced it secured a key U.S. patent for its <a href="https://www.benzinga.com/markets/equities/25/07/46435021/nuwellis-soars-31-25-in-after-hours-trading-whats-behind-the-surge">blood filtering technology</a>. 
What To Know: The U.S. Patent and Trademark Office officially granted the patent on Tuesday, Nuwellis announced after the market closed. The new patent, U.S. Patent No. 12,357,734, protects a method for improving the accuracy of fluid balance calculations in Continuous Renal Replacement Therapy. It addresses a <a href="https://www.benzinga.com/pressreleases/25/07/g46430062/nuwellis-secures-new-u-s-patent-strengthening-its-position-as-a-leader-in-fluid-management-innovat">known flaw</a> in current systems that use weight-based measurements and assume a standard fluid density.
Nuwellis says the company&#8217;s patented technology corrects for this by incorporating the actual density of replacement fluids and effluent, enabling more precise volumetric tracking and potentially improving patient outcomes.
&#8220;Expanding our intellectual property portfolio is a key part of our strategy,&#8221; said Nuwellis CEO John Erb, emphasizing the patent&#8217;s role in building long-term value.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, Nuwellis shares are trading higher by 161.2% to $18.10 Wednesday morning. The stock has a 52-week high of $196.98 and a 52-week low of $6.33.
Read Also: <a href="https://www.benzinga.com/markets/earnings/25/07/46440395/johnson-johnson-lifts-annual-forecast-after-strong-cancer-drugs-medtech-performance">Johnson &amp; Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance</a>
<h2 class="wp-block-heading">How To Buy NUWE Stock</h2>
By now you're likely curious about how to participate in the market for Nuwellis &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Nuwellis, which is trading at $6.89 as of publishing time, $100 would buy you 14.51 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

Nuwellis (NUWE) Stock Skyrockets On New Patent: What's Going On?

JMP Securities analyst Brian McKenna maintains SuRo Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSSS#NASDAQ">SSSS</a>) with a Market Outperform and raises the price target from $8 to $10.

SSSS

JMP Securities Maintains Market Outperform on SuRo Capital, Raises Price Target to $10

Truist Securities analyst David Macdonald maintains UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Buy and lowers the price target from $360 to $345.

Truist Securities Maintains Buy on UnitedHealth Group, Lowers Price Target to $345

SEGG Media Corporation, formerly Lottery.com Inc., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEGG#NASDAQ">SEGG</a>, LTRYW))) ("SEGG Media" or the "Company"), a leading technology company transforming the global intersection of sports, entertainment and gaming today announced a strategic investment into Veloce Media Group ("Veloce"), one of the fastest-scaling digital platforms operating at the intersection of sport, gaming, and content. The partnership will be managed by Sports.com, a division of SEGG Media.
The investment forms part of a broader buy-and-build strategy to position SEGG Media as the home of immersive sports and next-generation media. The transaction, which values Veloce at £40 million ($53 million USD) pre-money, will be completed in two tranches, with a call option enabling SEGG to reach majority ownership at 51%.
This move reinforces SEGG Media's recent launch and the turnaround success of&nbsp;<a href="https://www.globenewswire.com/Tracker?data=V6zE_6JkXdzX0UnfGrn4kq03jCPVtqO6174p2SwkLxwdkY46fIJ6ve6AvsU7M3SxHmCaBblRoqdxkGkeEI5EXw==">Lottery.com</a>. It signals a new phase of high-growth strategic acquisitions centered around profitability, scale, and exciting global fan engagement.

SEGG

SEGG Media Invests In Veloce Media Group At $53M Valuation To Accelerate Strategic Expansion In Esports, Motorsports And Immersive Digital Content

Truist Securities analyst David Smith maintains Bank of New York Mellon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) with a Hold and raises the price target from $97 to $100.

Truist Securities Maintains Hold on Bank of New York Mellon, Raises Price Target to $100

Press Releases

PureCycle Announces Preliminary Court Approval of Shareholder Derivative Settlement

PureCycle and Landbell Group Collaborate to Advance Polypropylene Plastic Recycling in Europe

PureCycle Announces Sale of Approximately $30 Million in Revenue Bonds

PureCycle Schedules First Quarter 2025 Corporate Update

PureCycle Provides Update on BOPP Film Trials

PureCycle Invites Ironton and Denver Communities to Tour Recycling Facilities

PureCycle Technologies First Quarter 2025 Corporate Update

PureCycle Announces $300 Million Capital Raise; Outlines Growth Plan for One Billion Pounds of Installed Capacity with Projected EBITDA of $600 Million Per Year By 2030

PureCycle Earns GreenCircle's Recycled Content Certification

PureCycle, Emerald Carpets Partner to Drive Circularity in Trade Show Industry

AdvanSix

Braskem

Bolt Projects Holdings, Inc. - Common Stock

Bolt Projects Holdings

Cabot

Core Molding Technologies Inc Common Stock

Core Molding Technologies

CN Energy Group Inc. - Class A Ordinary Shares

CN Energy Group

Gulf Resources

Hawkins

Koppers Holdings

Kronos Worldwide

Loop Industries

Mativ Holdings

Orion

Olin

Origin Materials, Inc. - Class A Common Stock

Origin Materials

PureCycle Technologies, Inc. - Common stock

Tronox Holdings

Trinseo

Westlake

Westlake Chemical Partners LP Common Units representing limited partner interests

Comments

PureCycle Technologies

Notizie

Ultime notizie per PureCycle Technologies (NASDAQ:PCT) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO